Stockreport

Wilmington Eye Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma [Yahoo! Finance]

Glaukos Corporation  (GKOS) 
Last glaukos corporation earnings: 2/27 04:15 pm Check Earnings Report
PDF WILMINGTON, NC / ACCESSWIRE / May 28, 2024 / Wilmington Eye is proud to announce the availability of iDose® TR (travoprost intraocular implant) 75 mcg. iDose TR is a ne [Read more]